Collectively, our findings proposed that CCL20 secreted by HPV-infected KRT15<sup>high</sup> tumor cells promoted TLS formation, thereby enhancing anti-PD-1 therapy responses in HPV<sup>+</sup>HNSCC. This evidence concerns the gene CCL20 and neoplasm.